{"id":"W2619342418","doi":"10.1126/scitranslmed.aaf3962","title":"The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis","year":2017,"lang":"en","type":"article","venue":"Science Translational Medicine","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":256,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institut Universitaire en Santé Mentale de Québec","funders":"Daiichi Sankyo Europe; Medical Research Council; Daiichi Sankyo Foundation of Life Science; Japan Agency for Medical Research and Development; Parkinson's UK; Research Center Network for Realization of Regenerative Medicine; Japan Society for the Promotion of Science; Mochida Memorial Foundation for Medical and Pharmaceutical Research","keywords":"Amyotrophic lateral sclerosis; Proto-oncogene tyrosine-protein kinase Src; ABL; Medicine; Neuroscience; Pharmacology; Cancer research; Biology; Receptor; Internal medicine; Tyrosine kinase; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["sts"],"consensus_categories":["sts"],"category_scores_codex":[0.002030588,0.0002257263,0.000342363,0.0002641504,0.001785402,0.0001859375,0.0009946793,0.00007094275,0.00078261],"category_scores_gemma":[0.0002740323,0.0001286502,0.0000970753,0.0005405808,0.004135719,0.0005481198,0.00008341205,0.0005101783,0.00006836442],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001259809,"about_ca_system_score_gemma":0.0005892956,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003633881,"about_ca_topic_score_gemma":0.00004902406,"domain_scores_codex":[0.9957916,0.00007353094,0.0004852107,0.0005881125,0.002251901,0.0008097145],"domain_scores_gemma":[0.9982442,0.0001172739,0.0001418834,0.0008521984,0.0003148942,0.0003295169],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.001141017,0.0002645951,0.1379673,0.00005678557,0.00008658415,0.0001301899,0.002710125,0.0001297735,0.7686642,0.006524238,0.0009334381,0.08139184],"study_design_scores_gemma":[0.002797971,0.0002763853,0.9776043,0.0002606092,0.00001841216,0.00003018803,0.00004392843,0.008535532,0.00104155,0.006550653,0.002688691,0.0001518098],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7375886,0.001007921,0.0003389748,0.2567549,0.0005748115,0.0007165158,0.00001242472,0.00004070912,0.002965103],"genre_scores_gemma":[0.9956715,0.0003478634,0.0004145481,0.002431839,0.0003485713,0.00004025862,0.000007746763,0.00002118965,0.0007164744],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.839637,"threshold_uncertainty_score":0.9995142,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06368197480743866,"score_gpt":0.3403339548035234,"score_spread":0.2766519799960848,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}